Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Aug;29(2):272–277.

Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity.

J Houwerzijl, G C De Gast, J P Nater, M T Esselink, H O Nieweg
PMCID: PMC1541085  PMID: 908175

Abstract

Seven cases of severe hypersensitivity to carbamazepine (Tegretol) were described in patients with epilepsy or trigeminal neuralgia. Clinical manifestations consisted of fever, rash, facial oedema, lymphadenopathy, impaired liver function, eosinophilia and atypical lymphocytes in the peripheral blood. Lymphocyte-stimulation tests with carbamazepine in vitro showed positive results in all cases; patch tests with carbamazepine were positive in six cases. In two cases the lymphocyte-stimulation tests with carbamazepine were found to be negative during, and shortly after, the illness. However, when the tests were repeated several months later, they turned out to be positive. Lymphocyte reactivity to PPD and PHA in vitro was also impaired during the acute phase of the disease. Thus false-negative lymphocyte-stimulation tests may be found in the first months following such a hypersensitivity reaction, probably due to impaired lymphocyte reactivity. As carbamazepine is a potent drug and is often prescribed for long periods together with other anticonvulsants, it seems important to prove that the allergic reaction is caused by carbamazepine. If the lymphocyte-stimulation test in vitro or the patch test with carbamazepine is found to be negative during or shortly after the illness, they should be repeated several months later.

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Du Bois M. G., Huismans D. R., Schellekens P. T., Eijsvoogel V. P. Investigation and standardization of the conditions for micro-lymphocyte cultures. Tissue Antigens. 1973;3(5):402–409. doi: 10.1111/j.1399-0039.1973.tb00510.x. [DOI] [PubMed] [Google Scholar]
  2. Fisher A. A. Systemic eczematous "contact-type" dermatitis medicamentosa. Ann Allergy. 1966 Aug;24(8):406–420. [PubMed] [Google Scholar]
  3. HOLLAND P., MAUER A. M. DRUG-INDUCED IN-VITRO STIMULATION OF PERIPHERAL LYMPHOCYTES. Lancet. 1964 Jun 20;1(7347):1368–1369. doi: 10.1016/s0140-6736(64)92046-x. [DOI] [PubMed] [Google Scholar]
  4. Heiss L. I., Palmer D. L. Anergy in patients with leukocytosis. Am J Med. 1974 Mar;56(3):323–332. doi: 10.1016/0002-9343(74)90614-7. [DOI] [PubMed] [Google Scholar]
  5. Leguit P., Jr, Meinesz A., Zeijlemaker W. P., Schellekens P. T., Eijsvoogel V. P. Immunological studies in burn patients. I. Lymphocyte transformation in vitro. Int Arch Allergy Appl Immunol. 1973;44(1):101–121. doi: 10.1159/000230921. [DOI] [PubMed] [Google Scholar]
  6. Levene G., Baker H. Drug reactions. II. Lymphocyte transformation in vitro and drug hypersensitivity. Br J Dermatol. 1968 Jun;80(6):415–417. [PubMed] [Google Scholar]
  7. MacKinney A. A., Booker H. E. Diphenylhydantoin effects on human lymphocytes in vitro and in vivo. An hypothesis to explain some drug reactions. Arch Intern Med. 1972 Jun;129(6):988–992. [PubMed] [Google Scholar]
  8. Mangi R. J., Niederman J. C., Kelleher J. E., Jr, Dwyer J. M., Evans A. S., Kantor F. S. Depression of cell-mediated immunity during acute infectious mononucleosis. N Engl J Med. 1974 Nov 28;291(22):1149–1153. doi: 10.1056/NEJM197411282912202. [DOI] [PubMed] [Google Scholar]
  9. PEARMAIN G., LYCETTE R. R., FITZGERALD P. H. Tuberculin-induced mitosis in peripheral blood leucocytes. Lancet. 1963 Mar 23;1(7282):637–638. doi: 10.1016/s0140-6736(63)91275-3. [DOI] [PubMed] [Google Scholar]
  10. SALTZSTEIN S. L., ACKERMAN L. V. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer. 1959 Jan-Feb;12(1):164–182. doi: 10.1002/1097-0142(195901/02)12:1<164::aid-cncr2820120122>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  11. Sarkany I. Lymphocyte transformation in drug hypersensitivity. Lancet. 1967 Apr 8;1(7493):743–745. doi: 10.1016/s0140-6736(67)91362-1. [DOI] [PubMed] [Google Scholar]
  12. Steen-Johnsen J. Alvorlige bivirkninger ved bruk av karbamazepin (Tegretol) Tidsskr Nor Laegeforen. 1970 Sep 1;90(17):1631–1632. [PubMed] [Google Scholar]
  13. Virolainen M. Blast transformation in vivo and in vitro in carbamazepin hypersensitivity. Clin Exp Immunol. 1971 Sep;9(3):429–435. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES